Association of metabolic changes with mortality of patients treated by peritoneal dialysis or hemodialysis

Renal Failure

Volumn 32, Issue 7, 2010, Pages 778-783

  Stolic, Radojica ^a   Trajkovic, Goran ^b   Jovanovic, Aleksandar ^a   Peric, Vladan ^a   Stolic, Dragica ^c   Sovtic, Sasa ^a   Subaric Gorgieva, Gordana ^a  

^a Faculty of Medicine   (Serbia)

^b Institute of Medical Statistics and Informatics   (Serbia)

^c The Health Center Pristina   (Serbia)

Author keywords

Hemodialysis; Metabolic changes; Mortality; Peritoneal dialysis

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN; PHOSPHATE;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY MASS; COMORBIDITY; DEMOGRAPHY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; METABOLIC DISORDER; METABOLIC SYNDROME X; MORTALITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; SMOKING; SURVIVAL; TREATMENT DURATION; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS; RENAL INSUFFICIENCY; SURVIVAL RATE;

EID: 77954874721     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.489168     Document Type: Article

References (25)

1. Chung SH, Heimbürger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: A comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005;20:1207-1213.
2. Khawar O, Kalantar-Zadeh K, Lo WK, Johnson D, Mehrotra R. Is the declining use of long-term peritoneal dialysis justified by outcome data? Clin J Am Soc Nephrol. 2007;2:1317-1328.
3. James HG, Hans L, Melvin M. Initial survival advantage of peritoneal dialysis relative to hemodialysis. Nephrol Dial Transplant. 2002;17:112-117.
4. Segall L, Covic A. Cardiovascular disease in hemodialysis and peritoneal dialysis: Arguments pro hemodialysis. Nephrol Dial Transplant. 2007;22:59-63.
5. Gokal R. Peritoneal dialysis in the 21st century: An analysis of current problems and future developments. J Am Soc Nephrol. 2002;13(Suppl):S104-S115.
6. Stolic R, Trajkovic G, Peric V, et al. Frequency and characteristics of metabolic disorders in patients on hemodialysis. Vojnosanit Pregl. 2008;65:205-209 (Serbian).
7. Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis. A propensity score approach. J Am Soc Nephrol. 2002;13:2353-2362.
8. Couchoud C, Moranne O, Frimat L, Labeeuw M, Allot V, Stengel B. Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease. Nephrol Dial Transplant. 2007;22:3246-3254.
9. Kim SG, Kim NH. The effect of residual renal function at the initiation of dialysis on patient survival. Korean J Intern Med. 2009;24:55-62.
10. Portoles J, del Peso G, Fernandez-Reyes MJ, Bajo MA, Lopez-Sanchez P, The GCDP. Previous comorbidity and lack of patient free choice of technique predict early mortality in peritoneal dialysis. Perit Dial Int. 2009;29:150-157.
11. Termorshuizen F, Korevaar JC, Dekker FW, et al. Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol. 2003;14:2851-2860.
12. Sigrist M, Bungay P, Taal MW, McIntyre CW. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant. 2006;21:707-714.
13. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6:184-191.
14. Van Biesen W, Verbeke F, Vanholder R. Cardiovascular disease in hemodialysis and peritoneal dialysis: Arguments pro peritoneal dialysis. Nephrol Dial Transplant. 2007;22:53-68.
15. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to hemodialysis. Nephrol Dial Transplant. 2002;17:112-117.
16. Vonesh EF, Moran J. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1999;10:354-365.
17. Inrig JK, Sun JL, Yang Q, Briley LP, Szczech LA. Mortality by dialysis modality among patients who have end-stage renal disease and are awaiting renal transplantation. Clin J Am Soc Nephrol. 2006;1:774-779.
18. Garcia-Lopes MG, Agliussi RG, Avesani CM, et al. Nutritional status and body composition after 6 months of patients switching from continuous ambulatorial peritoneal dialysis to automated peritoneal dialysis. Braz J Med Biol Res. 2008;41:1116-1122.
19. Kalantar-Zadeh K, Kopple JD, Regidor DL, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007;5:1049-1055.
20. Williams JD, Woods HF. Insulin resistance, the metabolic syndrome and renal failure - is there a special problem for patients treated with peritoneal dialysis? European Endocrine Review. 2006;29-34.
21. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol. 2003;14:2894-2901.
22. Haag-Weber M. The impact of residual diuresis on survival. Nephrol Dial Transplant. 2008;23:2123-2126.
23. Bargman JM, Golper TA. The importance of residual renal function for patients on dialysis. Nephrol Dial Transplant. 2005;20:671-673.
24. Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556-564.
25. Shemin D, Bostom, AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. J Am Kidney Dis. 2001;38:85-90.